Navigation Links
Response Biomedical Announces Insider Participation in Current Financing
Date:10/27/2008

d in the private placement have not been and will not be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States except pursuant to an available exemption from such registration requirements.

Statements contained in this press release relating to future results, events or developments, for example, statements containing the words "believes," "may," "could", "plans," "will," "estimate," "continue," "anticipates," "intends," expects", "goal" and similar expressions, are "forward-looking statements" or "forward-looking information" under applicable United States and Canadian securities laws. Forward-looking statements or information may involve, but are not limited to, comments with respect to the planned financing, our planned activities, business plan and strategies and their future implementation, and our expectations for our financial condition and the results of, or outlook for, our business operations generally. Forward-looking statements or information subject to the related assumptions made by us and involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from those express or implied by such statements or information.

Many of such risks, uncertainties and other factors form part of our underlying assumptions, and include, among other things, financial risks that would affect our operations such as our available working capital and cash flows and whether and for how long available funds will be sufficient to fund our operations and our ability to raise additional capital as and when needed; our need for substantial additional funding to conduct research and development and commercialization activities; changing facility costs and other risks relating to our facilities expansion plans; our ability to establish, and our dependence upon, relationships with strategic alliance partners to develop a
'/>"/>

SOURCE Response Biomedical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Hurricane Ike: World Vision Readies Supplies, Staff, Volunteers for Response
2. Monitoring immune responses in disease
3. Gustav: World Vision Teams Assist Evacuees in Jackson and Dallas, Prepare Response
4. Immune Response May Hinder Stem Cell Treatments
5. Study sees need for standardized evaluation of antibody response to HIV-1
6. Presidents Award Recognizes Hospitals Response to Bridge Collapse
7. Gene Variations May Predict Antidepressant Response
8. CSHL scientists correlate enzyme expression levels with chemotherapy drug response
9. FDA accepts Labopharms response for once-daily tramadol as complete Class 2 response
10. New study replicates association between genetic variation and antidepressant treatment response
11. Brain Cancer Vaccines Immune Response Key to Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... The world is at a "hinge ... to create new opportunities for leadership in health ... WesternU's 34th annual Commencement Exercises said Wednesday, May ... former San Francisco mayor and likely 2018 gubernatorial ... ceremony for WesternU's colleges of Allied Health Professions ...
(Date:5/22/2015)... May 22, 2015 Mountain Point Medical Center, ... ribbon cutting ceremony on Friday, May 29, 2015 at 11 ... 6 p.m. The new medical center, set to officially open ... Boulevard, Lehi, UT 84043. , “The opening of Mountain ... and the Utah County community,” said Kent Loosle, CEO of ...
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health Limited has ... Nature’s Way, Marc St-Onge has affirmed his commitment to ... an integral part of the agreement with Nature’s Way ... develop Ascenta Skin into a leading player in the ... anti-aging skincare supplement featuring 6 active ingredients including therapeutic ...
(Date:5/22/2015)... NY (PRWEB) May 22, 2015 Hands ... that June 17, 2015, the Annual One Day Sale ... Since 2007, Hands On HCMT offers drastically reduced certificates one ... and estheticians have enough sessions, through what used to be ... is wonderful for the community as well. This once a ...
(Date:5/22/2015)... May 22, 2015 Carnegie Science ... today announced a new partnership to develop BodyTech, a ... region. The initiative includes a new exhibit at the ... demonstration theater, and a new traveling science show, Anatomy ... of 2015. , Designed to explore a wide ...
Breaking Medicine News(10 mins):Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4
... Shows 9% Increase In Revenues - - Florida Upholds Contract Award To ... ... - Regional Tender Work Underway In U.K. -, PRINCETON, ... of identity DNA testing,services, today reported its financial results for the second quarter of,2008., ...
... 31 Nutraceutical,International Corporation (Nasdaq: NUTR ) today ... 30, 2008. Net sales for the fiscal,2008 third quarter ... quarter of fiscal 2007. For the third quarter of ... earnings per share, compared to,net income of $2.9 million, ...
... NeoGenomics, Inc.,(OTC Bulletin Board: NGNM) today announced its results ... included,the following:, Second Quarter 2008 Highlights: -- ... 17% sequential increase in revenue vs. Q1 08 -- ... initiative -- Average number of tests/requisition increased 8.0% to ...
... Cardiva Medical, Inc., a,privately held medical device company, announced ... the BMO Capital Markets 2008 Focus on,Healthcare conference on ... Broadway Hotel in New York City. Mr. Lien,s presentation ... growth,strategy., Details of the presentation follow: ...
... Sentrx, a leading provider of drug safety services, gained four new ... strategy (REMS). The company was also awarded a significant contract expansion. ... ... -- Sentrx, a leading provider of http://www.sentrx.com/drug_safety_services.shtml [drug safety ...
... their arsenal in their quest for gold. The team and their mounts ... Fish Oil for Horses® and Omega-Cure™ for humans, provided by the Venice, ... ... July 31, 2008 -- The U.S. Olympic eventing squad has a new ...
Cached Medicine News:Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 2Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 3Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 4Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 5Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 6Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 7Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 8Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 9Health News:Nutraceutical Reports Q3 Results 2Health News:Nutraceutical Reports Q3 Results 3Health News:Nutraceutical Reports Q3 Results 4Health News:Nutraceutical Reports Q3 Results 5Health News:Nutraceutical Reports Q3 Results 6Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 2Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 3Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 4Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 5Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 6Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 7Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 8Health News:Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference 2Health News:Sentrx Growth Continues with Four New Clients in Second Quarter 2Health News:Sentrx Growth Continues with Four New Clients in Second Quarter 3Health News:Fish Oil Fueling Equine Olympians 2Health News:Fish Oil Fueling Equine Olympians 3
(Date:5/22/2015)... May 22, 2015 According to ... by Product (Consumables, Instruments, Services), by Test Type (Indirect, ... Flow Cytometry), by End Users - Global Forecast to ... is expected to reach $736.85 Million by 2020 from ... 10.25%. Browse 71 market data Tables ...
(Date:5/22/2015)...  In a sweeping analysis assessing the current state ... researchers conclude that there remains considerable room for ... age groups, but especially for adolescents and young adults. ... treatment, underscoring the need to address barriers to care ... type 1 patients achieve optimal metabolic control. ...
(Date:5/21/2015)... 2015  When Ryan Rendino first felt ... his neck, he figured it was a ... off from weight lifting. But ... A series of doctor appointments ... Michel Kliot, MD , a ...
Breaking Medicine Technology:Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... 24 GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX) ... their candidate AIDS,vaccine failed to provide protection in a ... Merck trial involving high risk volunteers, an equal number ... Data Safety,Monitoring Board recommended that the trial be stopped ...
... 24 Progen Pharmaceuticals,Limited (ASX: PGL; Nasdaq: PGLA) ... of PI-88 in combination with the chemotherapeutic agent,docetaxel ... cancer did not meet,its primary endpoint of significantly ... docetaxel alone. The trial also did not meet ...
Cached Medicine Technology:GeoVax Labs, Inc. Comments on Discontinuance of Merck's HIV Vaccine Trial 2GeoVax Labs, Inc. Comments on Discontinuance of Merck's HIV Vaccine Trial 3GeoVax Labs, Inc. Comments on Discontinuance of Merck's HIV Vaccine Trial 4GeoVax Labs, Inc. Comments on Discontinuance of Merck's HIV Vaccine Trial 5Progen Announces PI-88 Phase 2 Lung Cancer Results 2
... patented ACS lenses offer the high resolution, ... the original clariVits. The simple two part ... its integrity during surgery. Simply autoclave, add ... then lock together for use. (ACS) AutoClave ...
... magnification and increased stereopsis, the ... for detailed visualization to the ... is ideal for vitrectomy in ... in proliferative vitreoretinopathy extending to ...
... Reinverting Operating Lens System® (ROLS) ... wide angle viewing system available ... unique single-element prism design, numerous ... viewing capability have made it ...
... Suturelysis lens provides unprecedented visibility of ... which, with other suturelysis lens designs, ... localized compressive forces and magnifies the ... resulting in enhanced visibility in difficult ...
Medicine Products: